Cuorips Inc. (4894.T)
JPY 6940.0
(0.43%)
JPY 6940.0
(0.43%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -632.18 Million JPY | -39.84% |
| 2022 | -452.07 Million JPY | -20.45% |
| 2021 | -375.33 Million JPY | -21.93% |
| 2020 | -307.83 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -192.71 Million JPY | -50.29% |
| 2023 FY | -632.18 Million JPY | -39.84% |
| 2023 Q4 | -128.22 Million JPY | 27.3% |
| 2023 Q3 | -176.38 Million JPY | -9.82% |
| 2023 Q1 | -166.95 Million JPY | -76.26% |
| 2023 Q2 | -160.61 Million JPY | 3.8% |
| 2022 FY | -452.07 Million JPY | -20.45% |
| 2022 Q4 | -94.72 Million JPY | 0.0% |
| 2021 FY | -375.33 Million JPY | -21.93% |
| 2020 FY | -307.83 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 264.631% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -19.978% |
| GNI Group Ltd. | 8.09 Billion JPY | 107.81% |
| Linical Co., Ltd. | 338.26 Million JPY | 286.889% |
| Trans Genic Inc. | 4.08 Million JPY | 15575.716% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 56.036% |
| Soiken Holdings Inc. | -662.2 Million JPY | 4.533% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 557.59% |
| AnGes, Inc. | -7.43 Billion JPY | 91.5% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 50.923% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 91.211% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 438.62% |
| NanoCarrier Co., Ltd. | -780 Million JPY | 18.951% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 45.166% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 47.71% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | 22.184% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -95.322% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 48.182% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 55.545% |
| PeptiDream Inc. | 3.03 Billion JPY | 120.824% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 67.388% |
| Ribomic Inc. | -1.02 Billion JPY | 38.278% |
| SanBio Company Limited | -2.64 Billion JPY | 76.09% |
| Healios K.K. | -3.82 Billion JPY | 83.464% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 45.879% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 57.56% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 55.773% |
| StemRIM | -2.02 Billion JPY | 68.735% |
| CellSource Co., Ltd. | 923.14 Million JPY | 168.482% |
| FunPep Company Limited | -933.41 Million JPY | 32.272% |
| Kringle Pharma, Inc. | -854.15 Million JPY | 25.987% |
| Stella Pharma Corporation | -763.74 Million JPY | 17.226% |
| TMS Co., Ltd. | -960.04 Million JPY | 34.15% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 44.055% |
| K Pharma,Inc. | 260.33 Million JPY | 342.839% |
| Takara Bio Inc. | 1.48 Billion JPY | 142.715% |
| ReproCELL Incorporated | -31.41 Million JPY | -1912.36% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 2496.63% |
| StemCell Institute Inc. | 310.98 Million JPY | 303.287% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 541.564% |
| CellSeed Inc. | -846.53 Million JPY | 25.321% |